| Molecular mechanisms of leptin and adiponectin in breast cancer T Jardé, S Perrier, MP Vasson, F Caldefie-Chézet European journal of cancer 47 (1), 33-43, 2011 | 354 | 2011 |
| Involvement of adiponectin and leptin in breast cancer: clinical and in vitro studies T Jardé, F Caldefie-Chézet, N Goncalves-Mendes, F Mishellany, ... Endocrine-related cancer 16 (4), 1197-1210, 2009 | 208 | 2009 |
| Leptin and leptin receptor involvement in cancer development: a study on human primary breast carcinoma T Jardé, F Caldefie-Chézet, M Damez, F Mishellany, F Penault-Llorca, ... Oncology reports 19 (4), 905-911, 2008 | 143 | 2008 |
| Mesenchymal niche-derived neuregulin-1 drives intestinal stem cell proliferation and regeneration of damaged epithelium T Jardé, WH Chan, FJ Rossello, TK Kahlon, M Theocharous, TK Arackal, ... Cell stem cell 27 (4), 646-662. e7, 2020 | 126 | 2020 |
| Wnt and Neuregulin1/ErbB signalling extends 3D culture of hormone responsive mammary organoids T Jardé, B Lloyd-Lewis, M Thomas, H Kendrick, L Melchor, L Bougaret, ... Nature communications 7 (1), 13207, 2016 | 123 | 2016 |
| Potential anti‐inflammatory effects of Melaleuca alternifolia essential oil on human peripheral blood leukocytes F Caldefie‐Chézet, C Fusillier, T Jarde, H Laroye, M Damez, MP Vasson, ... Phytotherapy research: an international journal devoted to pharmacological …, 2006 | 121 | 2006 |
| Clostridioides difficile infection damages colonic stem cells via TcdB, impairing epithelial repair and recovery from disease SJ Mileto, T Jardé, KO Childress, JL Jensen, AP Rogers, G Kerr, ... Proceedings of the National Academy of Sciences 117 (14), 8064-8073, 2020 | 95 | 2020 |
| ADAM 17 selectively activates the IL‐6 trans‐signaling/ERK MAPK axis in KRAS‐addicted lung cancer MI Saad, S Alhayyani, L McLeod, L Yu, M Alanazi, V Deswaerte, K Tang, ... EMBO molecular medicine 11 (4), e9976, 2019 | 80 | 2019 |
| Snai1 regulates cell lineage allocation and stem cell maintenance in the mouse intestinal epithelium K Horvay, T Jardé, F Casagranda, VM Perreau, K Haigh, CM Nefzger, ... The EMBO journal 34 (10), 1319-1335, 2015 | 70 | 2015 |
| Conditional disruption of Axin1 leads to development of liver tumors in mice GJ Feng, W Cotta, XQ Wei, O Poetz, R Evans, T Jardé, K Reed, V Meniel, ... Gastroenterology 143 (6), 1650-1659, 2012 | 70 | 2012 |
| Leptin induces a proliferative response in breast cancer cells but not in normal breast cells V Dubois, T Jardé, L Delort, H Billard, D Bernard-Gallon, E Berger, ... Nutrition and cancer 66 (4), 645-655, 2014 | 69 | 2014 |
| Personalized medicine—current and emerging predictive and prognostic biomarkers in colorectal cancer C Koulis, R Yap, R Engel, T Jardé, S Wilkins, G Solon, JD Shapiro, ... Cancers 12 (4), 812, 2020 | 64 | 2020 |
| Adiponectin, an anti-carcinogenic hormone? A systematic review on breast, colorectal, liver and prostate cancer S Perrier, T Jarde Current medicinal chemistry 19 (32), 5501-5512, 2012 | 58 | 2012 |
| Patient-derived colorectal cancer organoids upregulate revival stem cell marker genes following chemotherapeutic treatment RM Engel, WH Chan, D Nickless, S Hlavca, E Richards, G Kerr, K Oliva, ... Journal of clinical medicine 9 (1), 128, 2020 | 55 | 2020 |
| Adiponectin and leptin expression in primary ductal breast cancer and in adjacent healthy epithelial and myoepithelial tissue T Jardé, F Caldefie‐Chézet, M Damez, F Mishellany, D Perrone, ... Histopathology 53 (4), 484-487, 2008 | 55 | 2008 |
| Source and impact of the EGF family of ligands on intestinal stem cells HE Abud, WH Chan, T Jardé Frontiers in cell and developmental biology 9, 685665, 2021 | 54 | 2021 |
| Zinc-α2-glycoprotein: A new biomarker of breast cancer? V Dubois, L Delort, F Mishellany, T Jarde, H Billard, C Lequeux, ... Anticancer research 30 (7), 2919-2925, 2010 | 54 | 2010 |
| In vivo and in vitro models for the therapeutic targeting of Wnt signaling using a Tet-OΔN89β-catenin system T Jardé, RJ Evans, KL McQuillan, L Parry, GJ Feng, B Alvares, AR Clarke, ... Oncogene 32 (7), 883-893, 2013 | 51 | 2013 |
| New insights into anticarcinogenic properties of adiponectin: a potential therapeutic approach in breast cancer? L Delort, T Jardé, V Dubois, MP Vasson, F Caldefie-Chezet Vitamins & Hormones 90, 397-417, 2012 | 45 | 2012 |
| Evaluation of FGFR targeting in breast cancer through interrogation of patient-derived models NJ Chew, TCC Lim Kam Sian, EV Nguyen, SY Shin, J Yang, MN Hui, ... Breast Cancer Research 23, 1-20, 2021 | 42 | 2021 |
